The fact that they've waited this long leads me to believe they will put a higher offer on the table.
Guidant should be very appreciative of the fact that Boston Scientific has help raise shareholder value (for them).
What are they thinking about now? The fact that J&J is silent on that speaks volumes about what they had attempted to do before -- just to get a good price.